Well-controlled diabetes was associated with a lower risk of developing glaucoma, diabetic eye disease, and macular ...

Glaucoma is the second leading cause of blindness in the U.S.A primary screening tool for glaucoma is measurement of IOP. The ...

Many everyday symptoms are inconsequential. You have a poor night’s sleep to thank for your bloodshot eyes, or a new lotion ...

Primary open angle glaucoma and Alzheimer's disease have many similarities in pathophysiology and demographics. Could there be a common mechanisms linking the two diseases?

Promising Glaucoma Pipeline Therapies such as EYEOP1, Latanoprost 0.005%, POLAT-001, Ranibizumab, Mitomycin (MMC), PRM-151, ...

University of Salford, CSIR-IGIB and ORDI host glaucoma awareness and advocacy workshop: Our Bureau, Bengaluru Wednesday, July 2, 2025, 17:15 Hrs [IST] The University of Salford ( ...

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

Glaucoma UK has introduced a new tool to help the public understand their glaucoma risk, and highlighted its tools for eye ...

Shorter sleep duration may raise the risk for glaucoma and elevated IOP in patients with obstructive sleep apnea.

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with ...

Glaukos (NYSE:GKOS) announced that it received EU MDR certification for its iStent Infinite, along with several other ...

Decreased Aβ and increased tau in vitreous fluid (glaucoma) and cerebrospinal fluid (Alzheimer's disease) Blennow et al. 53 Nickells, 72 Quigley et al. , 73 Guo et al. 74 and Cordeiro et al. [ 55 ] ...